Affimed NV (AFMD)
5.35
0.00 (0.00%)
USD |
NASDAQ |
May 01, 16:00
5.35
0.00 (0.00%)
After-Hours: 18:07
Affimed Cash from Financing (TTM): -6.734M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -6.734M |
September 30, 2023 | -1.658M |
June 30, 2023 | -5.567M |
March 31, 2023 | 92.90M |
December 31, 2022 | 93.39M |
September 30, 2022 | 122.69M |
June 30, 2022 | 125.41M |
March 31, 2022 | 31.10M |
December 31, 2021 | 158.05M |
September 30, 2021 | 167.79M |
June 30, 2021 | 185.54M |
March 31, 2021 | 206.84M |
December 31, 2020 | 79.09M |
September 30, 2020 | 67.88M |
June 30, 2020 | 52.22M |
March 31, 2020 | 29.19M |
December 31, 2019 | 29.15M |
September 30, 2019 | -2.680M |
June 30, 2019 | -3.334M |
March 31, 2019 | -4.659M |
December 31, 2018 | 24.20M |
Date | Value |
---|---|
September 30, 2018 | 27.80M |
June 30, 2018 | 32.24M |
March 31, 2018 | 37.26M |
December 31, 2017 | 26.95M |
September 30, 2017 | 24.70M |
June 30, 2017 | 20.95M |
March 31, 2017 | 17.25M |
December 31, 2016 | -0.2612M |
September 30, 2016 | 19.89M |
June 30, 2016 | 21.94M |
March 31, 2016 | 59.37M |
December 31, 2015 | 59.37M |
September 30, 2015 | 37.29M |
June 30, 2015 | 95.09M |
March 31, 2015 | 59.70M |
December 31, 2014 | 59.70M |
September 30, 2014 | 60.67M |
June 30, 2014 | 5.501M |
March 31, 2014 | 6.752M |
December 31, 2013 | 6.752M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-6.734M
Minimum
Dec 2023
206.84M
Maximum
Mar 2021
74.80M
Average
67.88M
Median
Sep 2020
Cash from Financing (TTM) Benchmarks
InflaRx NV | 57.36M |
MorphoSys AG | -- |
BioNTech SE | -842.92M |
Immatics NV | 91.50M |
CureVac NV | 249.97M |